GlassScriptPhysician profile
James A Washburn
NPI 1902870009
$12,523.04
in general payments reported to CMS, 2019-2025
11 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $52.15 · 2021: $341 · 2022: $10K · 2023: $89.67 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,517 · Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,517.38 |
| Food and Beverage | $162.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,923.51 | 2021-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $136.75 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.98 | 2019-2021 | |
| Genzyme Corporation | $124.58 | 2022 | |
| Glaxosmithkline, LLC. | $57.77 | 2019-2025 | Trelegy Ellipta |
| Grifols USA, LLC | $56.82 | 2019 | |
| Mylan Specialty L.P. | $33.95 | 2020-2021 | |
| United Therapeutics Corporation | $18.73 | 2021 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Shire North American Group INC | $12.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $9.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Washburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.